David Shaw’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-50,000
| Closed | -$3.36M | – | 4679 |
|
|
2025
Q3 | $3.36M | Buy |
+50,000
| New | +$3.96M | ﹤0.01% | 2552 |
|
|
2025
Q1 | – | Sell |
-20,000
| Closed | -$1.56M | – | 4374 |
|
|
2024
Q4 | $1.56M | Hold |
20,000
| – | – | ﹤0.01% | 2914 |
|
|
2024
Q3 | $1.34M | Sell |
20,000
-4,200
| -17% | -$345K | ﹤0.01% | 3044 |
|
|
2024
Q2 | $2.74M | Buy |
24,200
+2,500
| +12% | +$316K | ﹤0.01% | 2346 |
|
|
2024
Q1 | $3.01M | Sell |
21,700
-12,400
| -36% | -$1.56M | ﹤0.01% | 2296 |
|
|
2023
Q4 | $4.23M | Buy |
34,100
+20,000
| +142% | +$2.04M | ﹤0.01% | 2044 |
|
|
2023
Q3 | $1.32M | Hold |
14,100
| – | – | ﹤0.01% | 2893 |
|
|
2023
Q2 | $1.81M | Sell |
14,100
-75,000
| -84% | -$9.07M | ﹤0.01% | 2687 |
|
|
2023
Q1 | $10.4M | Sell |
89,100
-195,900
| -69% | -$21.9M | 0.01% | 1336 |
|
|
2022
Q4 | $32.3M | Sell |
285,000
-28,000
| -9% | -$3.07M | 0.04% | 635 |
|
|
2022
Q3 | $25.2M | Buy |
313,000
+42,200
| +16% | +$3.57M | 0.03% | 716 |
|
|
2022
Q2 | $20.2M | Sell |
270,800
-59,200
| -18% | -$5.4M | 0.02% | 863 |
|
|
2022
Q1 | $42.2M | Sell |
330,000
-317,200
| -49% | -$34.7M | 0.04% | 567 |
|
|
2021
Q4 | $86.9M | Sell |
647,200
-13,200
| -2% | -$1.9M | 0.07% | 319 |
|
|
2021
Q3 | $90.3M | Buy |
660,400
+203,200
| +44% | +$25.6M | 0.08% | 289 |
|
|
2021
Q2 | $48.8M | Buy |
457,200
+167,600
| +58% | +$16.1M | 0.04% | 556 |
|
|
2021
Q1 | $26M | Sell |
289,600
-201,600
| -41% | -$18.9M | 0.03% | 790 |
|
|
2020
Q4 | $45.4M | Sell |
491,200
-8,400
| -2% | -$750K | 0.04% | 532 |
|
|
2020
Q3 | $51.5M | Buy |
499,600
+113,200
| +29% | +$11.8M | 0.05% | 411 |
|
|
2020
Q2 | $39.2M | Buy |
386,400
+138,400
| +56% | +$12.4M | 0.05% | 455 |
|
|
2020
Q1 | $16.7M | Sell |
248,000
-96,400
| -28% | -$6M | 0.03% | 726 |
|
|
2019
Q4 | $18.8M | Buy |
344,400
+244,400
| +244% | +$11.6M | 0.02% | 846 |
|
|
2019
Q3 | $3.73M | Hold |
100,000
| – | – | ﹤0.01% | 1868 |
|
|
2019
Q2 | $3.75M | Hold |
100,000
| – | – | ﹤0.01% | 1802 |
|
|
2019
Q1 | $2.98M | Hold |
100,000
| – | – | ﹤0.01% | 1883 |
|
|
2018
Q4 | $3M | Buy |
100,000
+20,000
| +25% | +$634K | ﹤0.01% | 1858 |
|
|
2018
Q3 | $2.86M | Buy |
+80,000
| New | +$2.48M | ﹤0.01% | 1949 |
|
|
2015
Q4 | – | Sell |
-79,200
| Closed | -$1.7M | – | 3835 |
|
|
2015
Q3 | $1.7M | Hold |
79,200
| – | – | ﹤0.01% | 2216 |
|
|
2015
Q2 | $1.58M | Buy |
+79,200
| New | +$1.39M | ﹤0.01% | 2378 |
|
|
2014
Q2 | – | Sell |
-24,800
| Closed | -$256K | – | 4263 |
|
|
2014
Q1 | $256K | Hold |
24,800
| – | – | ﹤0.01% | 3983 |
|
|
2013
Q4 | $220K | Buy |
+24,800
| New | +$196K | ﹤0.01% | 4220 |
|
Other funds holding DXCM
David Shaw's DXCM Position: Q2 2026 in Review
David Shaw reduced its DexCom (DXCM) stake by 80% in Q2 2026, selling an estimated $1.47M and leaving 5,679 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #4303.
David Shaw first reported a position in DXCM in Q3 2013 and has held it in 41 quarters since. The position peaked at $275M in Q4 2024. 966 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- David Shaw held 5,679 shares of DexCom worth $382K as of Q2 2026.
- David Shaw sold 22,053 DexCom shares in Q2 2026, an estimated $1.47M.
- DexCom made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4303 holding.
- David Shaw first reported a position in DexCom in Q3 2013 and has held it in 41 quarters since.
- David Shaw's DexCom position peaked at $275M in Q4 2024.
- 966 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.